explore -WSS

explore

author：explore 2025-09-03 03:42:26 - browse：237

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： RSV shot was 90% effective at preventing hospitalizations in kids

knowledge

WSS

Sen. Paul opposes bill to ban Chinese biotechs

The aspartame in Diet Coke probably isn’t giving you cancer

Air quality improving but still lags in Black, Hispanic communities

First medicine developed to treat MASH expected to be approved soon

Air quality improving but still lags in Black, Hispanic communities

Novo Nordisk obesity pill bests Wegovy in early trial

knowledge

explore

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

BioMarin wins approval for gene therapy to treat hemophilia A

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Medicare proposal to cover medical devices draws a mixed reaction

Teachers share how revamped forgiveness program helped with their student loans

Virginia high school admissions case could be legal follow

Precocious puberty in girls comes with mental health risks

Medical records are filled with copy

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

focus

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Teachers share how revamped forgiveness program helped with their student loans

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Precocious puberty in girls comes with mental health risks

focus

knowledge

hotspot

focus